CoChat

Combined Treatment With Exercise Training and Acarbose Improves Metabolic Control and Cardiovascular Risk Factor Profile in Subjects With Mild Type 2 Diabetes

Wagner, Henrik, Degerblad, Marie, Thorell, Anders, Nygren, Jonas, Ståhle, Agneta, Kuhl, Jeanette, Brismar, Torkel B., Öhrvik, John, Efendic, Suad, Båvenholm, Peter N. · 2006 · Diabetes Care
Cited by 55

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

OBJECTIVE—The effect of exercise training and acarbose on glycemic control, insulin sensitivity, and phenotype was investigated in mild type 2 diabetes. RESEARCH DESIGN AND METHODS—Sixty-two men and women with type 2 diabetes were randomized to 12 weeks of structured exercise training with or without acarbose treatment or to acarbose alone. Glycemic control was determined by HbA1c (A1C), insulin sensitivity (M value) by euglycemic-hyperinsulinemic clamp, and regional fat distribution by computerized tomography and dual X-ray absorptiometry. Physical fitness was determined as maximal oxygen uptake (Vo2max). All investigations were performed before and after the intervention. RESULTS—Forty-eight subjects completed the study. Exercise improved M value by 92% (P = 0.017) and decreased total and truncal fat (P = 0.002, 0.001) and systolic blood pressure (P = 0.01) but had no significant effect on Vo2max or A1C level. The combination of exercise and acarbose significantly decreased fasting plasma glucose, A1C, lipids, and diastolic blood pressure and increased Vo2max, whereas effects on M value and body composition were comparable with that of exercise alone. Acarbose alone had no significant effect on either M value or A1C but decreased systolic (P = 0.001) and diastolic blood pressure (P = 0.001) and fasting proinsulin level (P = 0.009). Multiple regression analysis showed that addition of acarbose to exercise improved glycemic control. CONCLUSIONS—In subjects with mild type 2 diabetes, exercise training improved insulin sensitivity but had no effect on glycemic control. The addition of acarbose to exercise, however, was associated with significant improvement of glycemic control and possibly cardiovascular risk factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc05-2513

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 22

  1. Unwin N, Shaw J, Zimmet P, Alberti KG: Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 19: 708–723, 2002 · DOI · Paper page
  2. The DECODE-study group, European Diabetes Epidemiology Group: Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies: Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe. Diabetologia 42:647–654, 1999 · DOI · Paper page
  3. Kelley DE, Goodpaster BH: Effects of exercise on glucose homeostasis in type 2 diabetes mellitus. Med Sci Sports Exerc 33:S495–S501, 2001 (discussion S528–S499) · DOI · Paper page
  4. Breuer HW: Review of acarbose therapeutic strategies in the long-term treatment and in the prevention of type 2 diabetes. Int J Clin Pharmacol Ther 41:421–440, 2003 · DOI
  5. Laube H, Linn T, Heyen P: The effect of acarbose on insulin sensitivity and proinsulin in overweight subjects with impaired glucose tolerance. Exp Clin Endocrinol Diabetes 106:231–233, 1998 · DOI
  6. Chiasson JL, Josse RG, Leiter LA, Mihic M, Nathan DM, Palmason C, Cohen RM, Wolever TM: The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance. Diabetes Care 19:1190–1193, 1996 · DOI · Paper page
  7. Meneilly GS, Ryan EA, Radziuk J, Lau DC, Yale JF, Morais J, Chiasson JL, Rabasa-Lhoret R, Maheux P, Tessier D, Wolever T, Josse RG, Elahi D: Effect of acarbose on insulin sensitivity in elderly patients with diabetes. Diabetes Care 23:1162–1167, 2000 · DOI · Paper page
  8. Fischer S, Patzak A, Rietzsch H, Schwanebeck U, Kohler C, Wildbrett J, Fuecker K, Temelkova-Kurktschiev T, Hanefeld M: Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients. Diabetes Obes Metab 5:38–44, 2003 · DOI
  9. Chang AM, Smith MJ, Bloem CJ, Galecki AT, Halter JB: Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance. Am J Physiol Endocrinol Metab 287:E906–E911, 2004 · DOI
  10. Jenney A, Proietto J, O’Dea K, Nankervis A, Traianedes K, D’Embden H: Low-dose acarbose improves glycemic control in NIDDM patients without changes in insulin sensitivity. Diabetes Care 16:499–502, 1993 · DOI · Paper page
  11. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223, 1979 · DOI · Paper page
  12. Bavenholm PN, Kuhl J, Pigon J, Saha AK, Ruderman NB, Efendic S: Insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation. J Clin Endocrinol Metab 88:82–87, 2003 · DOI · Paper page
  13. Astrand PO, Rodahl K: Textbook of Work Physiology. 3rd ed. Singapore, McGraw-Hill, 1986
  14. Borg GA: Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377–381, 1982 · DOI · Paper page
  15. American Diabetes Association: Clinical practice recommendations 2005. Diabetes Care 28(Suppl. 1):S1–S79, 2005 · DOI
  16. American Diabetes Association: Physical activity/exercise and diabetes (Position Statement). Diabetes Care 27(Suppl. 1):S58–S62, 2004 · DOI · Paper page
  17. Donahue RP, Abbott RD, Reed DM, Yano K: Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry: Honolulu Heart Program. Diabetes 36:689–692, 1987 · DOI
  18. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forhan A, Eschwege E: High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21:360–367, 1998 · DOI · Paper page
  19. Delorme S, Chiasson JL: Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus. Curr Opin Pharmacol 5:184–189, 2005 · DOI
  20. Seifarth C, Bergmann J, Holst JJ, Ritzel R, Schmiegel W, Nauck MA: Prolonged and enhanced secretion of glucagon-like peptide 1 (7–36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in type 2 diabetic patients. Diabet Med 15:485–491, 1998 · DOI · Paper page
  21. Rosenbaum P, Peres RB, Zanella MT, Ferreira SR: Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters. Braz J Med Biol Res 35:877–884, 2002 · DOI
  22. Hanefeld M, Haffner SM, Menschikowski M, Koehler C, Temelkova-Kurktschiev T, Wildbrett J, Fischer S: Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with type 2 diabetes. Diabetes Res Clin Pract 55:221–227, 2002 · DOI

Cited by

See all 55

Metadata

Authors
Wagner, H., Degerblad, M., Thorell, A., Nygren, J., Ståhle, A., Kuhl, J., Brismar, T. B., Öhrvik, J., Efendic, S., & Båvenholm, P. N.
Venue
Diabetes Care
Published
2006-07-01
Volume
29
Issue
7
Pages
1471-1477
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2165099877
Cited by
55
References
6
FWCI
3.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.